Drawing for ALPHA PRIME

USPTO serial 79215615

ALPHA PRIME

Reviewed by CopyMark Law Group

Reg. 5430591Status 706Registered
Filing date
Status date
Registration date
Mar 27, 2018
Examiner
BEVERLY, JOSETTE MICHELLE
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ALPHA PRIME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael K. Dixon

Michael K. Dixon Greenberg Traurig, P.A.777 South Flagler Drive, Suite 300 EastWest Palm Beach, FL 33401United States

Goods and services

ClassDescriptionStatusFirst use
005Natural pharmaceutical products, namely, natural remedy preparations and supplements for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, sleep disorders, depression or anxiety; herbal dietary supplements; antioxidants in the nature of dietary supplements; food supplements in the nature of dietary supplements; mineral food supplements; protein supplements for humans; vitamin supplements; nutritional supplements; pharmaceutical preparations containing amino acids, namely, amino acids for nutritional purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2026NOSUNOTICE OF SUIT—
Jul 9, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 2, 2025NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Jun 2, 202515AKREGISTERED - SEC. 15 ACKNOWLEDGED—
May 28, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
May 28, 2025E15RTEAS SECTION 15 RECEIVED—
Feb 5, 2025PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Feb 5, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 5, 202571AGREGISTERED-SEC.71 ACCEPTED—
Nov 18, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 27, 2024ES75TEAS SECTION 71 & 15 RECEIVED—
Mar 26, 2024ES71TEAS SECTION 71 RECEIVED—
Mar 27, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 21, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 7, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 7, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 7, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 7, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 3, 2022LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 5, 2021RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Nov 27, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 11, 2020NOSUNOTICE OF SUIT—
Nov 17, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 17, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 27, 2018FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 5, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 5, 2018FIMPFINAL DISPOSITION PROCESSED—
Jun 27, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 27, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 27, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jan 9, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 20, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 20, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 20, 2017NPUBNOTICE OF PUBLICATION—
Dec 3, 2017ALIEASSIGNED TO LIE—
Nov 25, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 16, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 16, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 16, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2017RFNTREFUSAL PROCESSED BY IB—
Sep 29, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 29, 2017RFRRREFUSAL PROCESSED BY MPU—
Sep 28, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 27, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2017DOCKASSIGNED TO EXAMINER—
Sep 12, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 8, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 7, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance